{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:27:25Z","timestamp":1793395645782,"version":"4.5.0"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["76822"],"award-info":[{"award-number":["76822"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118551","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:22:57Z","timestamp":1757910177000},"page":"118551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Innovative nanotechnology for infectious and inflammatory disease control: From diagnostics to therapeutics"],"prefix":"10.1016","volume":"191","author":[{"given":"Fatemeh","family":"Khosravi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Jahanban Esfahlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.publhealth.25.102802.124353","article-title":"Modeling infection transmission","volume":"25","author":"Koopman","year":"2004","journal-title":"Annu. Rev. Public Health"},{"issue":"8","key":"10.1016\/j.biopha.2025.118551_bib2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1473-3099(24)00158-0","article-title":"Global burden associated with 85 pathogens in 2019: a systematic analysis for the global burden of disease study 2019","volume":"24","author":"Naghavi","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41565-021-00866-8","article-title":"Nanotechnology approaches for global infectious diseases","volume":"16","author":"Kirtane","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118551_bib4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.drudis.2014.07.005","article-title":"An analysis of FDA-approved drugs for infectious disease: antibacterial agents","volume":"19","author":"Kinch","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.biopha.2025.118551_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol Spectr."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","author":"Huang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2025.118551_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/molecules21070867","article-title":"Advanced nanobiomaterials: vaccines, diagnosis and treatment of infectious diseases","volume":"21","author":"Torres-Sangiao","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118551_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.101626","article-title":"For and against tumor microenvironment: nanoparticle-based strategies for active cancer therapy","author":"Karimi","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2025.118551_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116951","article-title":"Recent advances in biomimetic cell membrane\u2013camouflaged nanoparticles for cancer therapy","volume":"177","author":"Alimohammadvand","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118551_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110297","article-title":"Amphotericin b loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection","volume":"128","author":"Kaur","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118551_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112753","article-title":"Controlled copper in situ growth-amplified lateral flow sensors for sensitive, reliable, and field-deployable infectious disease diagnostics","volume":"171","author":"Zhou","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.biopha.2025.118551_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jconrel.2020.11.019","article-title":"Intranasal delivery of interferon-\u03b2-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: a promising simple, effective, non-invasive, and low-cost therapy","volume":"331","author":"Gonz\u00e1lez","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118551_bib13","article-title":"Multifunctional nanostructures: intelligent design to overcome biological barriers","volume":"20","author":"Azizi","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"11","key":"10.1016\/j.biopha.2025.118551_bib14","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s11095-021-03143-4","article-title":"Potential application of exosomes in vaccine development and delivery","volume":"39","author":"Huda","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2025.118551_bib15","doi-asserted-by":"crossref","unstructured":"Tobin, E. and S. Brenner. Nanotechnology Fundamentals Applied to Clinical Infectious Diseases and Public Health in Open Forum Infectious Diseases. 2021. Oxford University Press US.","DOI":"10.1093\/ofid\/ofab583"},{"issue":"5","key":"10.1016\/j.biopha.2025.118551_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4161\/viru.2.5.17035","article-title":"The growing role of nanotechnology in combating infectious disease","volume":"2","author":"Blecher","year":"2011","journal-title":"Virulence"},{"issue":"4-5","key":"10.1016\/j.biopha.2025.118551_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.addr.2009.11.011","article-title":"Application of nanotechnologies for improved immune response against infectious diseases in the developing world","volume":"62","author":"Look","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118551_bib18","first-page":"25","article-title":"Application of nanotechnology in the treatment of infectious diseases: an overview","author":"Mba","year":"2022","journal-title":"Nanotechnol. Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2025.118551_bib19","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acsomega.3c09782","article-title":"Hyaluronic Acid-Targeted niosomes for effective breast cancer chemostarvation therapy","volume":"9","author":"Kaveh Zenjanab","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2025.118551_bib20","series-title":"Handbook for the Historiography of Science","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/978-3-031-27510-4_26","article-title":"Feynman\u2019s frameworks on nanotechnology in historiographical debate","author":"Pisano","year":"2023"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/acsanm.1c03033","article-title":"Silver nanoparticle-decorated personal protective equipment for inhibiting human coronavirus infectivity","volume":"5","author":"Abulikemu","year":"2021","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.biopha.2025.118551_bib22","series-title":"Artificial Life","first-page":"443","article-title":"Nano technology with feynman machines: scanning tunneling engineering and artificial life","author":"Schneiker","year":"2019"},{"issue":"24","key":"10.1016\/j.biopha.2025.118551_bib23","doi-asserted-by":"crossref","first-page":"24514","DOI":"10.1021\/acsnano.3c07741","article-title":"Nanovaccines for advancing long-lasting immunity against infectious diseases","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41467-023-44353-1","article-title":"The antibiotic resistance reservoir of the lung microbiome expands with age in a population of critically ill patients","volume":"15","author":"Chu","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2025.118551_bib25","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/vaccines10111946","article-title":"Nanoparticle-based delivery systems for vaccines","volume":"10","author":"Bezbaruah","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2025.118551_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.mattod.2023.04.008","article-title":"Nanocarrier vaccine therapeutics for global infectious and chronic diseases","volume":"66","author":"Simnani","year":"2023","journal-title":"Mater. Today"},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib27","first-page":"33","article-title":"Characteristics, challenges, and opportunities of vaccine cold chain","volume":"13","author":"Ren","year":"2021","journal-title":"Glob. Bus. Manag. Res. Int. J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2025.118551_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jconrel.2021.07.044","article-title":"Sialic acid-conjugate modified doxorubicin nanoplatform for treating neutrophil-related inflammation","volume":"337","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib30","first-page":"5482087","article-title":"Mucosal vaccine development based on liposome technology","volume":"2016","author":"Bernasconi","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118551_bib31","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1172\/JCI35433","article-title":"Pathogen destruction versus intracellular survival: the role of lipids as phagosomal fate determinants","volume":"118","author":"Steinberg","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib32","doi-asserted-by":"crossref","first-page":"45120","DOI":"10.1038\/srep45120","article-title":"Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance","volume":"7","author":"Poerio","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib33","article-title":"Nanotechnology-based approaches for targeted drug delivery for the treatment of respiratory tract infections","volume":"11","author":"Georgakopoulou","year":"2024","journal-title":"J. Biol. Methods"},{"issue":"5","key":"10.1016\/j.biopha.2025.118551_bib34","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/IAI.71.5.2498-2507.2003","article-title":"Role of innate immune factors in the adjuvant activity of monophosphoryl lipid a","volume":"71","author":"Martin","year":"2003","journal-title":"Infect. Immun."},{"issue":"16","key":"10.1016\/j.biopha.2025.118551_bib35","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/molecules25163731","article-title":"Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology","volume":"25","author":"Zieli\u0144ska","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12951-020-00714-2","article-title":"State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections","volume":"18","author":"Cano","year":"2020","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.arcmed.2023.02.003","article-title":"Protein-based nanoparticle vaccine approaches against infectious diseases","volume":"54","author":"Tapia","year":"2023","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.biopha.2025.118551_bib38","article-title":"Development of recombinant protein-based nanoparticle systems for inducing tumor cell apoptosis: in vitro evaluation of their cytotoxic and apoptotic effects on cancer cells","volume":"95","author":"Kaplan","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrd4503","article-title":"A holistic approach to targeting disease with polymeric nanoparticles","volume":"14","author":"Cheng","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib40","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/acsnano.9b01444","article-title":"Use of polymeric nanoparticle platform targeting the liver to induce treg-mediated antigen-specific immune tolerance in a pulmonary allergen sensitization model","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.118551_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120597","article-title":"Polymeric nanoparticle vaccines to combat emerging and pandemic threats","volume":"268","author":"Wibowo","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.118551_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biomaterials.2019.04.012","article-title":"Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release","volume":"209","author":"Peviani","year":"2019","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib43","first-page":"380","article-title":"A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2","volume":"22","author":"Yin","year":"2023","journal-title":"Nat. Mater."},{"issue":"12","key":"10.1016\/j.biopha.2025.118551_bib44","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/pharmaceutics13122091","article-title":"Nanovaccine delivery approaches and advanced delivery systems for the prevention of viral infections: from development to clinical application","volume":"13","author":"Cordeiro","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13205-020-2076-y","article-title":"Chitosan and chitosan nanoparticles as adjuvant in local rift valley fever inactivated vaccine","volume":"10","author":"El-Sissi","year":"2020","journal-title":"3 Biotech"},{"issue":"2","key":"10.1016\/j.biopha.2025.118551_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/mp100255c","article-title":"Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis b vaccine","volume":"8","author":"Thomas","year":"2011","journal-title":"Mol. Pharm."},{"issue":"13","key":"10.1016\/j.biopha.2025.118551_bib47","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/acs.iecr.0c05958","article-title":"Proteins as promising biobased building blocks for preparing functional hybrid protein\/synthetic polymer nanoparticles","volume":"60","author":"Cencha","year":"2021","journal-title":"Ind. Eng. Chem. Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118551_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4155\/tde-2021-0091","article-title":"Protein-based nanomaterials: a new tool for targeted drug delivery","volume":"13","author":"Aljabali","year":"2022","journal-title":"Ther. Deliv."},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib49","doi-asserted-by":"crossref","first-page":"e00503-23","DOI":"10.1128\/spectrum.00503-23","article-title":"Exosome-based multivalent vaccine: achieving potent immunization, broadened reactivity, and strong T-cell responses with nanograms of proteins","volume":"11","author":"Cacciottolo","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.biopha.2025.118551_bib50","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1080\/10942912.2023.2261662","article-title":"Recent advances in protein-based nanoparticles and their applications in the delivery of bioactive compounds","volume":"26","author":"Saif","year":"2023","journal-title":"Int. J. Food Prop."},{"issue":"44","key":"10.1016\/j.biopha.2025.118551_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202216097","article-title":"Protein-based nanoparticles: from drug delivery to imaging, nanocatalysis and protein therapy","volume":"62","author":"Kaltbeitzel","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/1567201820666230509101020","article-title":"An Up-to-date review on Protein-based nanocarriers in the management of cancer","volume":"21","author":"Almalki","year":"2024","journal-title":"Curr. Drug Deliv."},{"issue":"18","key":"10.1016\/j.biopha.2025.118551_bib53","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1021\/acs.nanolett.1c02251","article-title":"Confinement-dependent diffusiophoretic transport of nanoparticles in collagen hydrogels","volume":"21","author":"Doan","year":"2021","journal-title":"Nano Lett."},{"issue":"48","key":"10.1016\/j.biopha.2025.118551_bib54","doi-asserted-by":"crossref","first-page":"20550","DOI":"10.1039\/D1NR06137B","article-title":"Serum proteins on nanoparticles: early stages of the \u201cprotein corona","volume":"13","author":"McColman","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2025.118551_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108020","article-title":"One, two, many: strategies to alter the number of carbohydrate binding sites of lectins","volume":"60","author":"Tobola","year":"2022","journal-title":"Biotechnol. Adv."},{"issue":"2","key":"10.1016\/j.biopha.2025.118551_bib56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/med.21363","article-title":"Development and applications of lectins as biological tools in biomedical research","volume":"36","author":"Dan","year":"2016","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib57","doi-asserted-by":"crossref","DOI":"10.1088\/2632-959X\/ab8075","article-title":"Organic and inorganic nanoparticle vaccines for prevention of infectious diseases","volume":"1","author":"Poon","year":"2020","journal-title":"Nano Express"},{"key":"10.1016\/j.biopha.2025.118551_bib58","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.2147\/IJN.S76312","article-title":"Synthesis, characterization, and immune efficacy of layered double hydroxide@ SiO2 nanoparticles with shell-core structure as a delivery carrier for newcastle disease virus DNA vaccine","author":"Zhao","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118551_bib59","series-title":"Nanoparticle Vaccines Against Infectious Diseases","first-page":"2615","author":"Reljic","year":"2019"},{"issue":"13","key":"10.1016\/j.biopha.2025.118551_bib60","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1039\/C8CS00028J","article-title":"Tailoring inorganic nanoadjuvants towards next-generation vaccines","volume":"47","author":"Li","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2025.118551_bib61","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118551_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbon.2023.118058","article-title":"Nanotechnology in the COVID-19 era: carbon-based nanomaterials as a promising solution","volume":"210","author":"Papi","year":"2023","journal-title":"Carbon"},{"key":"10.1016\/j.biopha.2025.118551_bib63","article-title":"Do nanoparticles cause hormesis? Early physiological compensatory response in house crickets to a dietary admixture of GO, ag, and GOAg composite","volume":"788","author":"Alian","year":"2021","journal-title":"Sci. Total Environ."},{"issue":"10","key":"10.1016\/j.biopha.2025.118551_bib64","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/23\/10\/105101","article-title":"Light-activated nanotube\u2013porphyrin conjugates as effective antiviral agents","volume":"23","author":"Banerjee","year":"2012","journal-title":"Nanotechnology"},{"key":"10.1016\/j.biopha.2025.118551_bib65","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijbiomac.2022.01.146","article-title":"Multiwalled carbon nanotubes functionalized bacterial cellulose as an efficient healing material for diabetic wounds","volume":"203","author":"Khalid","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib66","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1166\/jbn.2020.2910","article-title":"Exosomes: applications in respiratory infectious diseases and prospects for coronavirus disease 2019 (COVID-19)","volume":"16","author":"Feng","year":"2020","journal-title":"J. Biomed. Nanotechnol."},{"issue":"15","key":"10.1016\/j.biopha.2025.118551_bib67","doi-asserted-by":"crossref","first-page":"2103222","DOI":"10.1002\/advs.202103222","article-title":"Exosome processing and characterization approaches for research and technology development","volume":"9","author":"Lai","year":"2022","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118551_bib68","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/vaccines10071119","article-title":"The big potential of small particles: lipid-based nanoparticles and exosomes in vaccination","volume":"10","author":"Shimon","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2025.118551_bib69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/mmr.2021.12542","article-title":"Possibility of exosome-based coronavirus disease 2019 vaccine (Review)","volume":"25","author":"Yoo","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2025.118551_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711565","article-title":"Exosome-based vaccines: history, current state, and clinical trials","volume":"12","author":"Santos","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib71","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/vaccines3040930","article-title":"From antigen delivery system to adjuvanticy: the board application of nanoparticles in vaccinology","volume":"3","author":"Boraschi","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2025.118551_bib72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2022.03.028","article-title":"Lung targeted liposomes for treating ARDS","volume":"346","author":"Raviv","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118551_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.01.054","article-title":"Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines","volume":"85","author":"Qiao","year":"2016","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biopha.2025.118551_bib74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Ther. Adv. Vaccin."},{"issue":"6","key":"10.1016\/j.biopha.2025.118551_bib75","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib76","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/vaccines3040894","article-title":"The use of synthetic carriers in malaria vaccine design","volume":"3","author":"Powles","year":"2015","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.biopha.2025.118551_bib77","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nano.2014.08.005","article-title":"A gold nanoparticle-linked glycoconjugate vaccine against burkholderia mallei","volume":"11","author":"Gregory","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"39","key":"10.1016\/j.biopha.2025.118551_bib78","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.vaccine.2015.08.025","article-title":"Nanovaccines for malaria using plasmodium falciparum antigen Pfs25 attached gold nanoparticles","volume":"33","author":"Kumar","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.biopha.2025.118551_bib79","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.vaccine.2015.01.062","article-title":"A gold glyco-nanoparticle carrying a listeriolysin o peptide and formulated with Advax\u2122 delta inulin adjuvant induces robust T-cell protection against listeria infection","volume":"33","author":"Rodriguez-Del Rio","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib80","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/acs.bioconjchem.5b00077","article-title":"Negatively charged glyconanoparticles modulate and stabilize the secondary structures of a gp120 V3 loop peptide: toward fully synthetic HIV vaccine candidates","volume":"26","author":"Gianvincenzo","year":"2015","journal-title":"Bioconj. Chem."},{"key":"10.1016\/j.biopha.2025.118551_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2022.133889","article-title":"Interactions between multi-walled carbon nanotubes and plankton as detected by Raman spectroscopy","volume":"295","author":"Howarth","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.biopha.2025.118551_bib82","article-title":"Emerging role of exosomes in tuberculosis: from immunity regulations to vaccine and immunotherapy","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118551_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.641421","article-title":"Novel virus-like particle vaccine encoding the circumsporozoite protein of plasmodium falciparum is immunogenic and induces functional antibody responses in mice","volume":"12","author":"Kurtovic","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118551_bib84","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.drudis.2022.02.014","article-title":"Stimuli-sensitive drug delivery systems for site-specific antibiotic release","volume":"27","author":"Nazir","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2025.118551_bib85","article-title":"Metal oxide nanocarrier for targeted drug delivery towards the treatment of global infectious diseases: a review","volume":"86","author":"Saha","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118551_bib86","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118551_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01908-5","article-title":"Recent advancement in nanotechnology-based drug delivery system against viral infections","volume":"22","author":"Pradhan","year":"2021","journal-title":"Aaps Pharmscitech"},{"issue":"5","key":"10.1016\/j.biopha.2025.118551_bib88","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbamem.2015.12.013","article-title":"Improving short antimicrobial peptides despite elusive rules for activity","volume":"1858","author":"Mikut","year":"2016","journal-title":"Biochim. Et. Biophys. Acta (BBA)Biomembr."},{"issue":"5","key":"10.1016\/j.biopha.2025.118551_bib89","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/AAC.06049-11","article-title":"Targeted intracellular delivery of antituberculosis drugs to mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles","volume":"56","author":"Clemens","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1-3","key":"10.1016\/j.biopha.2025.118551_bib90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-3659(97)00105-3","article-title":"Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after iv injection to rats","volume":"50","author":"L\u00f6benberg","year":"1998","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.biopha.2025.118551_bib91","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/iai.58.7.2139-2143.1990","article-title":"Activation of the plasma kallikrein-kinin system by candida albicans proteinase","volume":"58","author":"Kaminishi","year":"1990","journal-title":"Infect. Immun."},{"issue":"1-3","key":"10.1016\/j.biopha.2025.118551_bib92","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0169-409X(98)00095-7","article-title":"Liposomes for scintigraphic detection of infection and inflammation","volume":"37","author":"Laverman","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5153","key":"10.1016\/j.biopha.2025.118551_bib93","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib94","first-page":"1000003","article-title":"Exploitation of the macrophage mannose receptor (CD206) in infectious disease diagnostics and therapeutics","volume":"1","author":"Azad","year":"2014","journal-title":"J. Cytol. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib95","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2007.12.011","article-title":"Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections","volume":"127","author":"Chono","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118551_bib96","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2014.11.002","article-title":"Nanobody conjugated PLGA nanoparticles for active targeting of African trypanosomiasis","volume":"197","author":"Arias","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118551_bib97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejps.2018.10.017","article-title":"Combination drug therapy via nanocarriers against infectious diseases","volume":"127","author":"Walvekar","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib98","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s42770-021-00624-x","article-title":"Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies","volume":"52","author":"Rather","year":"2021","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.biopha.2025.118551_bib99","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2019.02.039","article-title":"Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of helicobacter pylori biofilm","volume":"300","author":"Li","year":"2019","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.biopha.2025.118551_bib100","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3390\/antibiotics11101374","article-title":"Combination of meropenem and zinc oxide nanoparticles; antimicrobial synergism, exaggerated antibiofilm activity, and efficient therapeutic strategy against bacterial keratitis","volume":"11","author":"El-Telbany","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.biopha.2025.118551_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.814340","article-title":"Aptamer-targeted drug delivery for staphylococcus aureus biofilm","volume":"12","author":"Ommen","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2025.118551_bib102","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.micpath.2018.11.023","article-title":"Reactive oxygen species inhibit biofilm formation of listeria monocytogenes","volume":"127","author":"Guo","year":"2019","journal-title":"Microb. Pathog."},{"issue":"18","key":"10.1016\/j.biopha.2025.118551_bib103","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1002\/chem.202004828","article-title":"Proanthocyanin-capped biogenic TiO2 nanoparticles with enhanced penetration, antibacterial and ROS mediated inhibition of bacteria proliferation and biofilm formation: a comparative approach","volume":"27","author":"Alomary","year":"2021","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.biopha.2025.118551_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121356","article-title":"Bacteria-targeting liposomes for enhanced delivery of cinnamaldehyde and infection management","volume":"612","author":"Sang","year":"2022","journal-title":"Int. J. Pharmaceutics."},{"issue":"7","key":"10.1016\/j.biopha.2025.118551_bib105","first-page":"770","article-title":"Targeted drug delivery using Tuftsin-bearing liposomes: implications in the treatment of infectious diseases and tumors","volume":"22","author":"Khan","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2025.118551_bib106","article-title":"Macrophage membrane-encapsulated carbon dots for precise targeting diagnosis and treatment of bacterial infections","author":"Cheng","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.118551_bib107","article-title":"Dual-targeted carbon-dot-drugs nanoassemblies for modulating alzheimer's related amyloid-\u03b2 aggregation and inhibiting fungal infection","volume":"12","author":"Yan","year":"2021","journal-title":"Mater. Today Bio"},{"issue":"35","key":"10.1016\/j.biopha.2025.118551_bib108","doi-asserted-by":"crossref","first-page":"2103442","DOI":"10.1002\/adfm.202103442","article-title":"Bacterial outer membrane-coated mesoporous silica nanoparticles for targeted delivery of antibiotic rifampicin against Gram-negative bacterial infection in vivo","volume":"31","author":"Wu","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.biopha.2025.118551_bib109","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/antibiotics8020039","article-title":"Rifampicin-loaded mesoporous silica nanoparticles for the treatment of intracellular infections","volume":"8","author":"Subramaniam","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.biopha.2025.118551_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.123184","article-title":"Quaternary ammonium chitosan-functionalized mesoporous silica nanoparticles: a promising targeted drug delivery system for the treatment of intracellular MRSA infection","volume":"352","author":"Liu","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2025.118551_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101330","article-title":"Targeted hot ion therapy of infected wound by glycol chitosan and polydopamine grafted Cu-SiO2 nanoparticles","volume":"41","author":"Xu","year":"2021","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.biopha.2025.118551_bib112","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10611860903483396","article-title":"Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses","volume":"18","author":"Al-Ghananeem","year":"2010","journal-title":"J. Drug Target."},{"issue":"28","key":"10.1016\/j.biopha.2025.118551_bib113","doi-asserted-by":"crossref","first-page":"2201853","DOI":"10.1002\/smll.202201853","article-title":"Antibiotic-Loaded amphiphilic chitosan nanoparticles target macrophages and kill an intracellular pathogen","volume":"18","author":"Trousil","year":"2022","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.biopha.2025.118551_bib114","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1021\/nn302538y","article-title":"Hyaluronic acid\u2013gold nanoparticle\/interferon \u03b1 complex for targeted treatment of hepatitis c virus infection","volume":"6","author":"Lee","year":"2012","journal-title":"ACS Nano"},{"issue":"39","key":"10.1016\/j.biopha.2025.118551_bib115","doi-asserted-by":"crossref","first-page":"33707","DOI":"10.1021\/acsami.7b13278","article-title":"Gold-decorated porous silicon nanopillars for targeted hyperthermal treatment of bacterial infections","volume":"9","author":"Alhmoud","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.118551_bib116","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jconrel.2015.10.052","article-title":"Bacteriomimetic invasin-functionalized nanocarriers for intracellular delivery","volume":"220","author":"Labouta","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118551_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-018-2521-3","article-title":"Aspherical and spherical InvA497-functionalized nanocarriers for intracellular delivery of anti-infective agents","volume":"36","author":"Castoldi","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2025.118551_bib118","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.2147\/IJN.S137338","article-title":"Application of nanodiagnostics in point-of-care tests for infectious diseases","author":"Wang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118551_bib119","series-title":"Microbial Processes for Synthesizing Nanomaterials","first-page":"213","article-title":"Nanodiagnostics for rapid and accurate detection of infectious diseases","author":"Siva Prasad","year":"2023"},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7150\/thno.8007","article-title":"Simple and sensitive detection of HBsAg by using a quantum dots nanobeads based dot-blot immunoassay","volume":"4","author":"Zhang","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118551_bib121","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-12-814966-9.00007-X","article-title":"Scientific advances in the diagnosis of emerging and reemerging viral human pathogens","author":"Hammou","year":"2020","journal-title":"Emerg. Reemerg. Viral Pathog."},{"issue":"9","key":"10.1016\/j.biopha.2025.118551_bib122","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/nl071415m","article-title":"Convergence of quantum dot barcodes with microfluidics and signal processing for multiplexed high-throughput infectious disease diagnostics","volume":"7","author":"Klostranec","year":"2007","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib123","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/am2013008","article-title":"Binding of HIV-1 gp120 glycoprotein to silica nanoparticles modified with CD4 glycoprotein and CD4 peptide fragments","volume":"4","author":"Cheng","year":"2012","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"23","key":"10.1016\/j.biopha.2025.118551_bib124","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnx234","article-title":"Nanoparticle-based lateral flow biosensor combined with multiple cross displacement amplification for rapid, visual and sensitive detection of vibrio cholerae","volume":"364","author":"Wang","year":"2017","journal-title":"FEMS Microbiol. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/diagnostics13030499","article-title":"Spectral photon-counting CT imaging of gold nanoparticle labelled monocytes for detection of atherosclerosis: a preclinical study","volume":"13","author":"Moghiseh","year":"2023","journal-title":"Diagnostics"},{"issue":"7","key":"10.1016\/j.biopha.2025.118551_bib126","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.7150\/thno.23856","article-title":"Applications of gold nanoparticles in virus detection","volume":"8","author":"Draz","year":"2018","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biopha.2025.118551_bib127","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1039\/D0MD00298D","article-title":"Functionalized gold nanoparticles: promising and efficient diagnostic and therapeutic tools for HIV\/AIDS","volume":"11","author":"Gulati","year":"2020","journal-title":"RSC Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib128","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.nano.2013.11.009","article-title":"Magnetic nanoparticle-based immunoassay for rapid detection of influenza infections by using an integrated microfluidic system","volume":"10","author":"Hung","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"4-5","key":"10.1016\/j.biopha.2025.118551_bib129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.addr.2009.11.014","article-title":"Nanobioimaging and sensing of infectious diseases","volume":"62","author":"Tallury","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118551_bib130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-90-481-9029-4_17","article-title":"Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications","author":"Mark","year":"2010","journal-title":"Microfluid. Based Microsyst. Fundam. Appl."},{"issue":"5","key":"10.1016\/j.biopha.2025.118551_bib131","doi-asserted-by":"crossref","first-page":"304","DOI":"10.18097\/pbmc20247005304","article-title":"Nanowire-based biosensors for solving biomedical problems","volume":"70","author":"Goldaeva","year":"2024","journal-title":"Biomeditsinskaya khimiya"},{"issue":"22","key":"10.1016\/j.biopha.2025.118551_bib132","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1039\/D1AN01096D","article-title":"Nanowire-based sensor electronics for chemical and biological applications","volume":"146","author":"Zhang","year":"2021","journal-title":"Analyst"},{"issue":"6","key":"10.1016\/j.biopha.2025.118551_bib133","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1021\/acsnano.8b01362","article-title":"A gold\/silver hybrid nanoparticle for treatment and photoacoustic imaging of bacterial infection","volume":"12","author":"Kim","year":"2018","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.biopha.2025.118551_bib134","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.7150\/thno.22621","article-title":"Dual-energy CT imaging of tumor liposome delivery after gold nanoparticle-augmented radiation therapy","volume":"8","author":"Ashton","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12951-022-01343-7","article-title":"The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118551_bib136","doi-asserted-by":"crossref","first-page":"eaax7964","DOI":"10.1126\/sciadv.aax7964","article-title":"Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke","volume":"5","author":"Zhang","year":"2019","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib137","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13054-019-2407-8","article-title":"Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis","volume":"23","author":"Col\u00f3n","year":"2019","journal-title":"Crit. Care"},{"issue":"10229","key":"10.1016\/j.biopha.2025.118551_bib138","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"lancet"},{"issue":"2","key":"10.1016\/j.biopha.2025.118551_bib139","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1763","article-title":"Inflammation-modulating nanoparticles for pneumonia therapy","volume":"14","author":"Muhammad","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2025.118551_bib140","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.2147\/IJN.S176087","article-title":"Immunotoxicity of titanium dioxide nanoparticles via simultaneous induction of apoptosis and multiple toll-like receptors signaling through ROS-dependent SAPK\/JNK and p38 MAPK activation","author":"Dhupal","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118551_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120098","article-title":"Anti-oxidant, anti-apoptotic, and mitochondrial regulatory effects of selenium nanoparticles against vancomycin induced nephrotoxicity in experimental rats","volume":"288","author":"Mehanna","year":"2022","journal-title":"Life Sci."},{"issue":"21","key":"10.1016\/j.biopha.2025.118551_bib142","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.3390\/ijms222111612","article-title":"Comparison of selenium nanoparticles and sodium selenite on the alleviation of early atherosclerosis by inhibiting endothelial dysfunction and inflammation in apolipoprotein E-deficient mice","volume":"22","author":"Xiao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118551_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2012.05.004","article-title":"Nanomedicines for chronic non-infectious arthritis: the clinician's perspective","volume":"8","author":"Rubinstein","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.biopha.2025.118551_bib144","article-title":"Nanotechnology for inflammatory bowel disease management: detection, imaging and treatment","volume":"32","author":"Barani","year":"2021","journal-title":"Sens. bio-sens. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/antibiotics14030289","article-title":"Silver nanoparticles: a versatile tool against infectious and Non-Infectious diseases","volume":"14","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"2025","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib146","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12951-023-01974-4","article-title":"Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy","volume":"21","author":"Wei","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118551_bib147","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/ibd\/izz205","article-title":"Nanotechnology in the treatment of inflammatory bowel disease","volume":"25","author":"Giron","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2025.118551_bib148","series-title":"Nanotechnology-based Advancements in NF-\u03baB Pathway Inhibition for the Treatment of Inflammatory Lung Diseases","first-page":"2209","author":"Bhat","year":"2022"},{"key":"10.1016\/j.biopha.2025.118551_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101577","article-title":"Nanotechnology reinforced neutrophil-based therapeutic strategies for inflammatory diseases therapy","volume":"46","author":"Wu","year":"2022","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.biopha.2025.118551_bib150","article-title":"Nanotechnology for cardiovascular diseases","volume":"3","author":"Hu","year":"2022","journal-title":"Innovation"},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib151","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1124\/jpet.118.254672","article-title":"CNS delivery and anti-inflammatory effects of intranasally administered cyclosporine-A in cationic nanoformulations","volume":"370","author":"Yadav","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2025.118551_bib152","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000488993","article-title":"Tretinoin loaded nanoemulsion for acne vulgaris: fabrication, physicochemical and clinical efficacy assessments","volume":"31","author":"Sabouri","year":"2018","journal-title":"Ski. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2025.118551_bib153","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jconrel.2020.05.028","article-title":"Structural optimization of HPMA copolymer-based dexamethasone prodrug for improved treatment of inflammatory arthritis","volume":"324","author":"Jia","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib154","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ndt\/gfx204","article-title":"Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia\u2013reperfusion injury in the rat","volume":"33","author":"Van Alem","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"issue":"21","key":"10.1016\/j.biopha.2025.118551_bib155","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1158\/1078-0432.CCR-17-1082","article-title":"Preclinical evaluation of intravesical cisplatin nanoparticles for non\u2013muscle-invasive bladder cancer","volume":"23","author":"Kates","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118551_bib156","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.01.008","article-title":"Current applications of nanoparticles in infectious diseases","volume":"224","author":"Zazo","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118551_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.768461","article-title":"A survey of preclinical studies evaluating nanoparticle-based vaccines against non-viral sexually transmitted infections","volume":"12","author":"Abisoye-Ogunniyan","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118551_bib158","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/infdis\/jir370","article-title":"The critical need for alternative antiretroviral formulations, and obstacles to their development","volume":"204","author":"Swindells","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib159","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/COH.0000000000000164","article-title":"Formulation and pharmacology of long-acting rilpivirine","volume":"10","author":"Williams","year":"2015","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/COH.0000000000000168","article-title":"Formulation and pharmacology of long-acting cabotegravir","volume":"10","author":"Trezza","year":"2015","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib161","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41467-018-02885-x","article-title":"Creation of a long-acting nanoformulated dolutegravir","volume":"9","author":"Sillman","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib162","doi-asserted-by":"crossref","first-page":"01316","DOI":"10.1128\/AAC.01316-17","article-title":"Pharmacokinetics of a long-acting nanoformulated dolutegravir prodrug in rhesus macaques","volume":"62","author":"McMillan","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib163","doi-asserted-by":"crossref","first-page":"13184","DOI":"10.1038\/ncomms13184","article-title":"Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies","volume":"7","author":"Giardiello","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib164","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118551_bib165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2008.06.012","article-title":"Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria","volume":"362","author":"Joshi","year":"2008","journal-title":"Int. J. Pharmaceutics"},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118551_bib166","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2008.06.021","article-title":"Development of SMEDDS using natural lipophile: application to \u03b2-artemether delivery","volume":"362","author":"Mandawgade","year":"2008","journal-title":"Int. J. Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118551_bib167","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2147\/IJN.S76317","article-title":"Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice","author":"Melariri","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118551_bib168","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2015.02.050","article-title":"Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety","volume":"485","author":"Singh","year":"2015","journal-title":"Int. J. Pharmaceutics."},{"issue":"5-6","key":"10.1016\/j.biopha.2025.118551_bib169","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tube.2005.08.009","article-title":"Oral solid lipid nanoparticle-based antitubercular chemotherapy","volume":"85","author":"Pandey","year":"2005","journal-title":"Tuberculosis"},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tube.2004.11.003","article-title":"Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis","volume":"85","author":"Pandey","year":"2005","journal-title":"Tuberculosis"},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib171","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijantimicag.2005.07.012","article-title":"Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis","volume":"26","author":"Zahoor","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"9","key":"10.1016\/j.biopha.2025.118551_bib172","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines\u2014lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2025.118551_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114083","article-title":"Clinical translation of nanomedicines: challenges, opportunities, and keys","volume":"181","author":"Younis","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118551_bib174","first-page":"1","article-title":"Infectious diseases: overview, challenges, and perspectives","author":"Vazquez-Munoz","year":"2023","journal-title":"Smart Nanomater. Combat Spread Viral Infect."},{"issue":"20","key":"10.1016\/j.biopha.2025.118551_bib175","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.2217\/nnm-2016-0281","article-title":"Nanoparticles and the immune system: challenges and opportunities","volume":"11","author":"Grabbe","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2025.118551_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2020.100276","article-title":"A european nano-registry as a reliable database for quantitative risk assessment of nanomaterials? A comparison of national approaches","volume":"21","author":"Pavlicek","year":"2021","journal-title":"NanoImpact"},{"issue":"3","key":"10.1016\/j.biopha.2025.118551_bib177","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/nano11030581","article-title":"Silver nanoparticle-based nanocomposites for combating infectious pathogens: recent advances and future prospects","volume":"11","author":"Wahab","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2025.118551_bib178","series-title":"Environmental Nanotoxicology: Combatting the Minute Contaminants","first-page":"267","article-title":"Risk assessment and management in nanotoxicology","author":"Isibor","year":"2024"},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib179","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/nano13010020","article-title":"Development of new health risk assessment of nanoparticles: EPA health risk assessment revised","volume":"13","author":"Macko","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2025.118551_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2023.112452","article-title":"In silico nanotoxicology: the computational biology state of art for nanomaterial safety assessments","volume":"235","author":"Verma","year":"2023","journal-title":"Mater. Des."},{"issue":"2","key":"10.1016\/j.biopha.2025.118551_bib181","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00289-023-04755-z","article-title":"A clinical perspective of chitosan nanoparticles for infectious disease management","volume":"81","author":"Dilnawaz","year":"2024","journal-title":"Polym. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib182","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2018.183","article-title":"Non-invasive delivery strategies for biologics","volume":"18","author":"Anselmo","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118551_bib183","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17425247.2024.2440618","article-title":"Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes","volume":"22","author":"Mazumdar","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.biopha.2025.118551_bib184","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00204-023-03471-x","article-title":"Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review","volume":"97","author":"Singh","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2025.118551_bib185","first-page":"2024","article-title":"Evaluating the impact of artificial intelligence on vaccine development: lessons learned from the COVID-19 pandemic","author":"Farahani","year":"2024","journal-title":"MedRxiv"},{"key":"10.1016\/j.biopha.2025.118551_bib186","series-title":"2021 IEEE International Conference on Big Data (Big Data)","article-title":"AI-driven agent-based models to study the role of vaccine acceptance in controlling COVID-19 spread in the US","author":"Bhattacharya","year":"2021"},{"key":"10.1016\/j.biopha.2025.118551_bib187","doi-asserted-by":"crossref","first-page":"1191147","DOI":"10.3389\/fmed.2023.1191147","article-title":"Personalized Medicine and infectious disease management","volume":"10","author":"Haddad-Boubaker","year":"2023","journal-title":"Front. Med."},{"issue":"23","key":"10.1016\/j.biopha.2025.118551_bib188","doi-asserted-by":"crossref","first-page":"15038","DOI":"10.3390\/ijms232315038","article-title":"The potential of antibiotics and nanomaterial combinations as therapeutic strategies in the management of multidrug-resistant infections: a review","volume":"23","author":"Adeniji","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:11:52Z","timestamp":1773108712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":188,"alternative-id":["S0753332225007450"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118551","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative nanotechnology for infectious and inflammatory disease control: From diagnostics to therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118551"}}